Comments on: Dissecting Novartis’ Comments to the FDA on the Use of Social Media http://prforpharma.com/2010/03/18/dissecting-novartis%e2%80%99-comments-to-the-fda-on-the-use-of-social-media/#utm_source=feed&utm_medium=feed&utm_campaign=feed Discussions about social media, PR and marketing for pharmaceutical companies Thu, 19 Jan 2012 21:23:35 +0000 hourly 1 http://wordpress.org/?v=3.1.1 By: uberVU - social comments http://prforpharma.com/2010/03/18/dissecting-novartis%e2%80%99-comments-to-the-fda-on-the-use-of-social-media/comment-page-1/#comment-568 uberVU - social comments Mon, 22 Mar 2010 19:23:51 +0000 http://prforpharma.com/?p=188#comment-568 <strong>Social comments and analytics for this post...</strong> This post was mentioned on Twitter by PRforPharma: A look at Novartis' comments to the FDA on social media: http://bit.ly/czf2ul, including the proposal to redefine AE reporting system... Social comments and analytics for this post…

This post was mentioned on Twitter by PRforPharma: A look at Novartis’ comments to the FDA on social media: http://bit.ly/czf2ul, including the proposal to redefine AE reporting system…

]]> By: RandstadPharma http://prforpharma.com/2010/03/18/dissecting-novartis%e2%80%99-comments-to-the-fda-on-the-use-of-social-media/comment-page-1/#comment-976 RandstadPharma Fri, 19 Mar 2010 18:01:23 +0000 http://prforpharma.com/?p=188#comment-976 <span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">RT @PRforPharma What do you think about NVS' #fdasm comments? Pos? Neg? meh? http://bit.ly/czf2ul (via @bradatpharma)</span></span> RT @PRforPharma What do you think about NVS' #fdasm comments? Pos? Neg? meh? http://bit.ly/czf2ul (via @bradatpharma)

]]> By: bradatpharma http://prforpharma.com/2010/03/18/dissecting-novartis%e2%80%99-comments-to-the-fda-on-the-use-of-social-media/comment-page-1/#comment-977 bradatpharma Fri, 19 Mar 2010 17:55:08 +0000 http://prforpharma.com/?p=188#comment-977 <span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">Good to see discussion #iwork@novartis // RT @PRforPharma What do you think about NVS' #fdasm comments? Pos? Neg? meh? http://bit.ly/czf2ul</span></span> Good to see discussion #iwork@novartis // RT @PRforPharma What do you think about NVS' #fdasm comments? Pos? Neg? meh? http://bit.ly/czf2ul

]]> By: Chris Iafolla http://prforpharma.com/2010/03/18/dissecting-novartis%e2%80%99-comments-to-the-fda-on-the-use-of-social-media/comment-page-1/#comment-978 Chris Iafolla Thu, 18 Mar 2010 23:06:37 +0000 http://prforpharma.com/?p=188#comment-978 <span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">A look at Novartis' comments to the FDA on social media: http://bit.ly/czf2ul, including the proposal to redefine AE reporting system</span></span> A look at Novartis' comments to the FDA on social media: http://bit.ly/czf2ul, including the proposal to redefine AE reporting system

]]> By: Chris Iafolla http://prforpharma.com/2010/03/18/dissecting-novartis%e2%80%99-comments-to-the-fda-on-the-use-of-social-media/comment-page-1/#comment-979 Chris Iafolla Thu, 18 Mar 2010 23:06:29 +0000 http://prforpharma.com/?p=188#comment-979 <span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">A look at Novartis' comments to the FDA on social media: http://bit.ly/czf2ul, including the proposal to redefine AE reporting system.</span></span> A look at Novartis' comments to the FDA on social media: http://bit.ly/czf2ul, including the proposal to redefine AE reporting system.

]]>